Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials

IMPORTANCE: Adalimumab was recently approved for the treatment of noninfectious intermediate uveitis, posterior uveitis, and panuveitis. OBJECTIVE: To assess the effect of adalimumab on the visual functioning and quality of life in patients with corticosteroid-dependent noninfectious intermediate uv...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JAMA Ophthalmol
Egile Nagusiak: Sheppard, John, Joshi, Avani, Betts, Keith A., Hudgens, Stacie, Tari, Samir, Chen, Naijun, Skup, Martha, Dick, Andrew D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Medical Association 2017
Gaiak:
Original Investigation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5847080/
https://ncbi.nlm.nih.gov/pubmed/28426849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2017.0603
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak